FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

17471811000001102: Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Jul 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
60478101000001116 Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
60478201000001111 Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Is a Mebendazole 100mg/5ml oral suspension 30 ml true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has AMP Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has specific active ingredient Mebendazole true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Vermox 100mg/5ml oral suspension (Mawdsley-Brooks & Company Ltd) 30 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start